Companies like Lovable, Base44, Replit, and Netlify use AI to let anyone build a web app in seconds—and in thousands of cases ...

In a high-profile matchup, Kevin Durant and the Houston Rockets (52-30) will face LeBron James and the Lakers (53-29) in the first round of the 2026 NBA playoffs. Game 1 tips off in Los Angeles on ...

The FBI has deployed additional investigators and resources to Minnesota, a move FBI Director Kash Patel said Sunday was intended to strengthen ongoing fraud investigations, Reuters reports. The ...

But Crepeau's heroics elsewhere in the half helped the Central Florida side escape with a point. His best denial came against Max Arfsten in the 76th minute, and he also reacted well to thwart Daniel ...

Substitute Luis Suarez scored his first goal of the season in the 82nd minute after Lionel Messi scored his fifth and Inter Miami salvaged a 2-2 draw against visiting Austin FC to officially open ...

NAR rolled out an expertise-driven application for its 2027 governance committees, starting with a required expertise profile. The update follows plans to sunset some groups as NAR streamlines its ...

Colorado Parks and Wildlife (CPW) wants to remind hunters that the deadline to submit a big-game draw application in the primary draw is approaching fast. Submit your application at cpwshop.com by ...

AUSTIN, Texas — Tuesday marks the deadline for Texas families to apply for the state’s new Education Freedom Accounts program, which has already drawn more than 200,000 student applications, according ...

WSJ’s David Uberti explains what’s happening in the global oil market and how oil reserves could impact the U.S. economy. Photo: Brandon Bell/Getty Images After the 1973 oil shock, the U.S. and allies ...

Groundbreaking tool enables financial advisors to provide AI-optimized investment solutions via Syntax Direct™ custom indexing platform Syntax Data, a leader in financial data and technology, today ...

Following the submission in December 2025, USFDA has accepted Dr. Reddy’s 351(k) Biologics License Application (BLA) for Proposed Interchangeable biosimilar Abatacept, DRL_AB (IV for Infusion) BLA is ...